Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Interest Expenses (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Interest Expenses for 4 consecutive years, with -$467225.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses fell 3279.05% to -$467225.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $113592.0, a 52.44% increase, with the full-year FY2024 number at $92475.0, up 197.15% from a year prior.
  • Interest Expenses was -$467225.0 for Q3 2025 at bioAffinity Technologies, down from $483043.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $889091.0 in Q3 2022 to a low of -$467225.0 in Q3 2025.
  • A 4-year average of $112682.5 and a median of $18867.0 in 2024 define the central range for Interest Expenses.
  • Biggest YoY gain for Interest Expenses was 2071.08% in 2025; the steepest drop was 3279.05% in 2025.
  • bioAffinity Technologies' Interest Expenses stood at $89290.0 in 2022, then crashed by 84.3% to $14021.0 in 2023, then soared by 486.9% to $82289.0 in 2024, then crashed by 667.79% to -$467225.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Interest Expenses are -$467225.0 (Q3 2025), $483043.0 (Q2 2025), and $15485.0 (Q1 2025).